(Q50860074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Kelly A Avery-Kiejda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Nikola A Bowden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rodney J Scott

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

23 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

301-305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

The prognostic importance of triple negative breast carcinoma

4 March 2020

cites work

1 reference

Triple-Negative Breast Cancer

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

21 January 2018

1 reference

Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer

21 January 2018

1 reference

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

21 January 2018

1 reference

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

21 January 2018

1 reference

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

21 January 2018

1 reference

Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer

21 January 2018

1 reference

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

21 January 2018

1 reference

PALB2 is an integral component of the BRCA complex required for homologous recombination repair

21 January 2018

1 reference

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.

21 January 2018

1 reference

PALB2/FANCN: recombining cancer and Fanconi anemia

21 January 2018

1 reference

PALB2 mutations in familial breast and pancreatic cancer

21 January 2018

1 reference

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

21 January 2018

1 reference

Analysis of PALB2/FANCN-associated breast cancer families

21 January 2018

1 reference

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

21 January 2018

1 reference

SIFT: Predicting amino acid changes that affect protein function

21 January 2018

1 reference

Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.

21 January 2018

1 reference

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

21 January 2018

1 reference

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

21 January 2018

1 reference

Germline mutations in PALB2 in African-American breast cancer cases

21 January 2018

1 reference

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer

21 January 2018

1 reference

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals

21 January 2018

1 reference

PALB2 sequence variants in young South African breast cancer patients

21 January 2018

1 reference

PALB2 mutations in German and Russian patients with bilateral breast cancer

21 January 2018

1 reference

Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer.

21 January 2018

1 reference

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

21 January 2018

1 reference

A PALB2 mutation associated with high risk of breast cancer

21 January 2018

1 reference

Structural basis for recruitment of BRCA2 by PALB2

21 January 2018

1 reference

PALB2 links BRCA1 and BRCA2 in the DNA-damage response

21 January 2018

1 reference

Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles

21 January 2018

1 reference

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?

21 January 2018

1 reference

Therapeutic strategies for triple-negative breast cancer

21 January 2018

1 reference

T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy

21 January 2018

1 reference

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination

21 January 2018

1 reference

Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations

21 January 2018

1 reference

Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

21 January 2018

1 reference

PALB2 mutations in male breast cancer: a population-based study in Central Italy

21 January 2018

1 reference

A PALB2 germline mutation associated with hereditary breast cancer in Italy

21 January 2018

1 reference

Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility

21 January 2018

1 reference

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23824750%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference